Mumilk
Cell-cultured human milk components for infant nutrition and functional foods
Highlights
- Young companyFounded 2023
- Hiring3 open roles
- New on EvolcAdded 2026-11-20
About Mumilk
Nūmi develops cell-culture processes to recreate components of breast milk in vitro, with the aim of producing nutrition products for infants and people of all ages. Its work includes bioactive compounds such as human milk oligosaccharides and lactoferrin.
The company aims to offer parents an alternative when breastfeeding is not an option and to explore broader applications of its research in functional foods. It is based in Évry-Courcouronnes, France, and was founded in 2023.
Its team includes cell scientists, research engineers and bioprocess engineers. Open roles include process engineering, cell biology and analytical development positions in Paris.
Product: Cell-culture processes and developing nutrition products based on components of human breast milk.
Jobs at Mumilk (3)
Mumilk is hiring for 3 roles, mostly in data & AI and engineering, based in Paris.
Senior Downstream Process Engineer
Young companyNew on EvolcAnalytical Development Lead
Young companyNew on EvolcCell Biologist Intern
Young companyNew on Evolc
Companies hiring like Mumilk
Leadership
- Eden Banon-Lagrange · Co-founder & CEOSource: company website
- Eugénie Pezé-Heidsieck · Co-founder & CTOSource: company website
More biotech & pharma companies
Mycea
Develops fungal-extract crop protection candidates for agricultural and biocontrol partnersNaemos
Plant-based cosmetic active ingredients from indoor-farmed microgreens and eco-extraction, sold to cosmetic brandsYoung companyNanobiotix
Clinical-stage biotech developing physics-based nanotherapeutics, led by the cancer radioenhancer NBTXR3, for solid tumoursNanomedsyn
Develops M6PR-targeting glycoligands for biotech and pharmaceutical developers of targeted therapeuticsNew on EvolcNanoreviv
Develops localized antibiotic formulations for pharmaceutical partners and patients with local infectionsYoung companyNew on EvolcNaobios
GMP development and manufacturing services for companies developing viral vaccines, vectors and other virus-based products
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- WorkableMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.